JSE SENS Announcements

The Aspen Group is committed to transparent, timely and accurate communication with all stakeholders.

DateSENS Statement
7 December 2016

AGM Voting (126.6 KiB)

4 November 2016

No Change Statement - AGM Date (76.7 KiB)

14 October 2016

Dealing In Securities By Director's Associates (68.0 KiB)

13 October 2016

Dealing In Aspen Securities (73.1 KiB)

13 October 2016

Dealing In Aspen Securities By Directors And Company Secretary (68.1 KiB)

5 October 2016

Correction - Aspen GSK S122 Announcement (73.4 KiB)

5 October 2016

Aspen GSK S122 Announcement (76.3 KiB)

29 September 2016

GSK Share Disposal (40.0 KiB)

14 September 2016

Aspen Unaudited Year End Results Commentary (SENS) (105.4 KiB)

12 September 2016

Aspen Year End Results Presentation (45.2 KiB)

12 September 2016

Aspen GSK Announcement (1.2 MiB)

7 September 2016

Aspen Trading Statement (60.1 KiB)

1 September 2016

Aspen Clearance Announcement (56.4 KiB)

16 August 2016

General Meeting Proceedings (56.2 KiB)

12 August 2016

Maureen Manyama Appointment To Social & Ethics Committee (43.1 KiB)

15 July 2016

Aspen Notice Of A General Meeting Of Shareholders (184.1 KiB)

DateSENS Statement
9 June 2016

Aspen AstraZeneca Anaesthetics Announcement (93.0 KiB)

8 June 2016

Aspen Facilities Arrangement (67.1 KiB)

17 May 2016

HPC Agreement (57.0 KiB)

31 March 2016

Appointment Of Non-Executive Director (54.8 KiB)

3 March 2016

Aspen Unaudited Interim Financial Results - Six Months December 2015 (84.5 KiB)

1 March 2016

Interim Results (57.1 KiB)

23 February 2016

Trading Statement (67.3 KiB)

19 February 2016

Aspen HPC Announcement (49.5 KiB)

19 January 2016

Change Of Transfer Secretary (53.7 KiB)

8 December 2015

Aspen AGM Voting (79.0 KiB)

1 December 2015

Voluntary Announcement - McGuff HPC (51.7 KiB)

19 November 2015

Dealing In Securities By The Company Secretary (49.6 KiB)

10 November 2015

Dealing In Securities By Directors (66.2 KiB)

3 November 2015

No Change Statement AGM Date (52.7 KiB)

9 September 2015

Aspen Unaudited Year-End Results Announcement (86.8 KiB)

7 September 2015

Aspen YE Results And Presentation (47.9 KiB)

28 August 2015

Voluntary Trading Statement (51.3 KiB)

12 August 2015

Resignation As Directors And Chairman - Appointment Of Chairman (48.2 KiB)

11 August 2015

Aspen - Strides Conditions Precedent Fulfilled (46.6 KiB)

5 August 2015

Renewal Of Aspen Cautionary Announcement (46.7 KiB)

DateSENS Statement
30 June 2015

BEE Imithi Unwind Announcement (54.2 KiB)

25 June 2015

Renewal Of Aspen Cautionary Announcement (53.3 KiB)

21 May 2015

Aspen Strides Product Divestment Agreement (45.1 KiB)

14 May 2015

Aspen Cautionary (50.9 KiB)

11 May 2015

Aspen Litha Divestment Agreement (57.7 KiB)

20 March 2015

GSK S122 Announcement (58.3 KiB)

20 March 2015

Rafique Bagus Resignation - Non Executive Director (41.6 KiB)

16 March 2015

Directors Dealings (56.0 KiB)

13 March 2015

GSK 2015 Share Disposal (41.3 KiB)

5 March 2015

Unaudited interim results for the six months ended 31 December 2014 (570.1 KiB)

23 February 2015

Aspen interim results and results presentation (41.2 KiB)

23 January 2015

Aspen Acquisition Of Mono-Embolex (48.2 KiB)

24 December 2014

ARV Tender Results (54.4 KiB)

10 December 2014

Report On AGM Proceedings (83.7 KiB)

10 December 2014
5 December 2014
11 November 2014

11 Nov 2014 - Clarification Of Return Date (39.1 KiB)

31 October 2014

Aspen Acquires IMF Facility In NZ (44.3 KiB)

30 October 2014

No Change Statement & AGM Date (59.8 KiB)

23 October 2014

Aspen Deferred Bonus Shares (28.8 KiB)

20 October 2014

Aspen acquisition of selected license rights to TSX-002 and an equity stake in TesoRx (55.4 KiB)

9 October 2014

Aspen GSK Strategic Alliance In Japan (70.0 KiB)

10 September 2014

Aspen 2014 year end results announcement (514.2 KiB)

8 September 2014

Confirmation Of 2014 Year End Results (144.0 KiB)

3 September 2014

JSE - Pre-closed Period Conference Call (57.0 KiB)

29 August 2014

Trading Statement 29th August 2014 (65.8 KiB)

DateSENS Statement
29 June 2014

Aspen Clarification Closed Period Call (31.5 KiB)

27 June 2014

27 June 2014 Dealings By A Director Of A Major Subsidiary (72.2 KiB)

20 May 2014

20 May 2014 Dealing In Securities (71.5 KiB)

19 May 2014

19 May 2014 Appointment Of Non-executive Director (73.8 KiB)

6 March 2014

Dec 2013 Results Booklet (2.0 MiB)

21 February 2014

21 February 2014 - Voluntary Trading Statement (62.8 KiB)

31 December 2013

31 December - Aspens Acquisition Of MSD Products (50.9 KiB)

31 December 2013

31 December - Aspens Acquisition Of GSK Brands And Business Worldwide (61.9 KiB)

20 December 2013

20 December - Competition Tribunal Approval For Aspen's Acquisition Of IN Businesses From Nestle (46.3 KiB)

4 December 2013

4 December - Dealings In Securities By A Director (43.4 KiB)

4 December 2013

4 December - Results Of The AGM (40.9 KiB)

19 November 2013

19 November - DEALING IN SECURITIES BY DIRECTORS AND BY DIRECTORS OF A MAJOR SUBSIDIARY (52.6 KiB)

11 November 2013

11 November - Results Of Extraordinary Shareholders Meeting To Approve Proposed GSK Transaction (51.7 KiB)

4 November 2013

4 November 2013 No Change Statement (45.9 KiB)

31 October 2013

31 October - Further Announcement Regarding The Acquisition From MSD (55.9 KiB)

28 October 2013

28 October 2013 Aspen Completion Of Acquisition Of Infant Nutritional Business In Latin America From Nestlé (48.6 KiB)

24 October 2013

24 October 2013 Aspen Acquisition Funding (64.8 KiB)

10 October 2013

Aspen Circular And General Meeting Annnouncement 10 October 2013 (49.5 KiB)

1 October 2013

Acquisition Of Manufacturing Business And Products From MSD (52.9 KiB)

30 September 2013

30 September 2013 - Acquisition Of GSK Brands And Manufacturing Site In France (149.4 KiB)

13 September 2013

13 Sept 2013 Acquisition Finance Facilities (87.7 KiB)

13 September 2013

13 Sept 2013 Record Date (57.1 KiB)

11 September 2013

Aspen Reviewed Provisional Results Booklet For The Year Ended 30 June 2013 (541.3 KiB)

5 September 2013

Aspen SENS 05 Sep 2013 Renewal Of Cautionary Announcement - GSK Discussions (68.5 KiB)

30 August 2013

30 Aug 2013 Trading Update (63.7 KiB)

7 August 2013

7 Aug Aspen Voluntary Announcement (80.6 KiB)

24 July 2013

24 July 2013 Cautionary Announcement (70.3 KiB)

DateSENS Statement
27 June 2013

Aspen MSD SENS Announcement 27 June 2013 (113.2 KiB)

18 June 2013

18 June 2013 Cautionary Announcement (67.9 KiB)

3 June 2013

3 June 2013 Renewal Of Cautionary Announcement MSD (64.6 KiB)

23 April 2013

23 April 2013 Renewal Of Cautionary Announcement (61.3 KiB)

18 April 2013

18 April 2013 Aspen Acquisition Of Nestle Businesses - Voluntary Announcement (80.1 KiB)

7 March 2013

Aspen Interim Results Booklet 2013 (444.5 KiB)

21 February 2013

Aspen Trading Statement 21 Feb 2013 (64.3 KiB)

4 February 2013

Aspen SENS 4 Feb 2013 MSD (351.2 KiB)

4 December 2012

Results Of The Annual General Meeting - 4 Dec 2012 (69.4 KiB)

4 December 2012

4 December 2012 - Directors Dealings (72.4 KiB)

3 December 2012

Completion Of Aspen Globals Acquisition Of Australian Product Portfolio From GSK (79.2 KiB)

27 November 2012

Director's Dealings - 27 November 2012 (76.9 KiB)

23 November 2012

Director's Dealings - 23 November 2012 (75.5 KiB)

5 November 2012

Change Statement And Notice Of Annual General Meeting - 5 Nov 2012 (74.1 KiB)

2 November 2012

Director's Dealings - 2 Nov 2012 (84.6 KiB)

1 November 2012

Director's Dealings - 1 Nov 2012 (79.5 KiB)

5 October 2012

Director's Dealings - 5 Oct 2012 (78.5 KiB)

2 October 2012

Director's Dealings - 2 Oct 2012 (83.4 KiB)

14 September 2012

Director's Dealings - 14 Sept 2012 (83.6 KiB)

12 September 2012

Aspen Year End Financial Results Press Release - 12 Sept 2012 (94.4 KiB)

12 September 2012

Aspen Financial Results And Capital Distribution - 12 Sept 2012 (857.1 KiB)

5 September 2012

Change In Aspens BEE Shareholding - 5 Sept 2012 (83.5 KiB)

30 August 2012

Trading Statement - 30 August 2012 (78.9 KiB)

15 August 2012

Aspen Global Acquires Australian Product Portfolio - 15 Aug 2012 (103.8 KiB)

DateSENS Statement
8 June 2012

Dealing In Aspen Securities By A Director Of A Major Subsidiary - 8 Jun 2012 (78.1 KiB)

7 June 2012

Changes In Aspen's BEE Shareholding - 7 Jun 2012 (89.1 KiB)

7 June 2012

Director's Dealings - 7 June 2012 (77.6 KiB)

2 May 2012

Director's Dealings - 2 May 2012 (77.7 KiB)

25 April 2012

Director's Dealings - 25 April 2012 (78.4 KiB)

20 April 2012

Aspen Announces Multi-Territory Acquisition Of GSK OTC Products For R2.1 Billion - 20 Apr 2012 (87.0 KiB)

26 March 2012

Director's Dealings - 26 March 2012 (77.1 KiB)

9 March 2012

Appointment Of Non Excecutive Director - 9 Mar 2012 (80.7 KiB)

7 March 2012

Aspen Increases Revenue By 31 Percent - 7 March 2012 (98.4 KiB)

7 March 2012

Unaudited Interim Financial Results - 7 March 2012 (413.1 KiB)

21 February 2012

Trading Statement 21 Feb 2012 (77.6 KiB)

20 January 2012

Director's Dealings - 20 Jan 2012 (78.8 KiB)

1 December 2011

1 Dec 2011 Results Of AGM And Appointment Of Company Secretary (67.2 KiB)

1 December 2011

1 Dec 2011 Response To Bloomberg Report (65.7 KiB)

2 November 2011

2 Nov 2011 No Change Statement And Notice Of AGM (70.2 KiB)

12 October 2011

12 Oct 2011 Resignation Of Director (60.6 KiB)

23 September 2011

23 Sept 2011 Dealings In Securities By Director Of Subsidiary (63.0 KiB)

16 September 2011

16 Sept 2011 Dealing In Securities By Director And Company Secretary (68.8 KiB)

13 September 2011

13 Sept 2011 Aspen Year End Results As At 30 June 2011 (198.0 KiB)

2 September 2011

2 Sept 2011 Trading Update (65.7 KiB)

15 August 2011

15 Aug 2011 Appointment Of Company Secretary (60.3 KiB)

8 August 2011

8 Aug 2011 Resignation Of Company Secretary (61.3 KiB)

DateSENS Statement
29 June 2009

29 June 2009 Director's Dealings (63.6 KiB)

24 June 2009

24 June 2009 Dealings In Securities By A Director (73.2 KiB)

24 June 2009

24 June 2009 Director Dealins In Shares (62.9 KiB)

12 June 2009

12 June 2009 Aspen & Frankel Chemicals (87.6 KiB)

12 May 2009

12 May 2009 Aspen And GSK Agree On Multiple Stategic Transactions (102.2 KiB)

26 March 2009

26 March 2009 Renewal Of Cautionary Announcement (59.5 KiB)

5 March 2009

5 Mar 2009 Interim Results 31Dec2008 (163.8 KiB)

2 March 2009

02 March 2009 Resignation Of Pasco Dyani (62.7 KiB)

19 February 2009

19 February 2009 Renewal Of Cautionary Announcement (59.0 KiB)

12 February 2009

12 February 2009 Trading Updates (67.7 KiB)

30 January 2009

30 January 2009 Sarvier Perindopril (71.6 KiB)

13 January 2009

13 January 2009 Cautionary Announcement (58.2 KiB)

10 December 2008

10 December 2008 Dealings In Securities By A Director (68.8 KiB)

3 December 2008

03 December Dealing In Securities By Director (63.7 KiB)

3 December 2008

03 December Directors' Dealings (68.5 KiB)

28 November 2008

28 November 2008 AGM Results (62.1 KiB)

7 November 2008

07 November 2008 Posting Of AR (62.5 KiB)

29 October 2008

29 October 2008 Directors' Dealings (61.7 KiB)

24 October 2008

24 October 2008 JSE Listing Requirements (69.6 KiB)

16 October 2008

16 October 2008 Finalisation Of Term Loan Funding Facility (77.4 KiB)

9 October 2008

09 October 2008 Voluntary Transcaction Announcement (68.5 KiB)

3 October 2008

03 October 2008 Director's Dealings (70.7 KiB)

16 September 2008

16 Sept Review Preliminary Group Financial Results 30 June 2008 (191.4 KiB)

16 September 2008

16 September 2008 International Platform For Future Growth (77.5 KiB)

16 September 2008

16 September 2008 Revision Of Terms Latin American Operations (74.8 KiB)

26 August 2008

26 August 2008 New Appointment To The Board (73.3 KiB)

23 July 2008

23 July 2008 Aspen Licensing Deal With GSK (74.2 KiB)

16 July 200816 July 2008 Withdrawal of cautionary announcement